Swiss pharma Roche is staying in lockstep with Eli Lilly, expanding its AI offerings and Nvidia partnership shortly after the ...

One of the world’s largest hearing aid retailers plans to bring a top manufacturer under its roof in a major acquisition that ...

Astellas is pulling out of its $1.6 billion biobucks partnership with CytomX Therapeutics six years after the two companies set out to explore T-cell-engaging bispecifics for the treatment of solid ...

An analysis of grant data, conducted by a former NIH center director, reveals that the NIH has awarded 1,189 grants this fiscal year, compared to 2,322 at the same time last year.

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

Novo Holdings saw its assets shrink by a third last year as part of the fallout of Novo Nordisk’s nosediving share price. | ...

China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...

By Matthew Harrington, Global Head, Clinical Product, Syneos Health | Artificial intelligence (AI) now features prominently in boardroom and executive discussions across the life sciences industry.

Inovio Pharmaceuticals has laid off staff and prioritized programs to focus on its lead rare disease candidate, which is ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...